The stock's rise snapped a three-day losing streak.
43m
Hosted on MSNHere's Why ResMed (RMD) is a Strong Growth StockIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Buying $1000 In RMD: If an investor had bought $1000 of RMD stock 10 years ago, it would be worth $3,648.09 today based on a ...
ResMed (NYSE:RMD) has had a rough month with its share price down 7.5%. However, stock prices are usually driven by ...
Shares of ResMed Inc. RMD slipped 1.03% to $230.58 Tuesday, on what proved to be an all-around great trading session for the ...
New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships7 out of 10 employed respondents have called in sick at least onc ...
ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth opportunities in the sleep apnea market.
ResMed Inc. (NYSE:RMD – Free Report) – Zacks Research reduced their Q4 2026 earnings per share (EPS) estimates for shares of ResMed in a research note issued on Wednesday, February 19th.
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced upcoming changes to the Company's Board of Directors, including: ...
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2024. Revenue increased by 10% to $1.3 billion; up 10% on a constant currency basis Gross margin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results